Increasing participation in cervical cancer screening: Telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial

International Journal of Cancer

Volumn 133, Issue 1, 2013, Pages 164-171

  Broberg, Gudrun ^a,b   Jonasson, Junmei Miao ^a,c   Ellis, Joy ^b   Gyrd Hansen, Dorte ^d,e   Anjemark, Birgitta ^f   Glantz, Anna ^b   Söderberg, Lotta ^g   Ryd, Mare Liis ^a   Holtenman, Mikael ^a   Milsom, Ian ^b   Strander, Björn ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^f Frölunda Torg Antenatal Clinic   (Sweden)

^g Borås Antenatal Clinic   (Sweden)

Author keywords

cervical intraepithelial neoplasia; mass screening; non attendance; Papanicolaou smear; telephone reminder

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; INTERVENTION STUDY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT ATTITUDE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SWEDEN; TELECONSULTATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS IDENTIFICATION; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; COST-BENEFIT ANALYSIS; DNA, VIRAL; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; RISK; SWEDEN; TELEPHONE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84876694462     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27985     Document Type: Article

References (37)

1. IARC. Cervix cancer screening. In: IARC, ed. Handbooks of cancer prevention, vol. 10. Lyon: IARC Press, 2005.
2. Gustafsson L, Ponten J, Zack M, et al. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 1997; 8: 755-63.
3. Mahlck CG, Jonsson H, Lenner P,. Pap smear screening and changes in cervical cancer mortality in Sweden. Int J Gynaecol Obstet 1994; 44: 267-72.
4. Bray F, Loos AH, McCarron P, et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 2005; 14: 677-86.
5. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-9.
6. Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-65.
7. Goldie SJ, Kohli M, Grima D, et al. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. J Natl Cancer Inst 2004; 96: 604-15.
8. Franco EL, Harper DM,. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. Vaccine 2005; 23: 2388-94.
9. Andrae B, Kemetli L, Sparen P, et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst 2008; 100: 622-9.
10. Sung HY, Kearney KA, Miller M, et al. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000; 88: 2283-9.
11. Lindqvist PG, Hellsten C, Rippe A,. Screening history of women in Malmo with invasive cervical cancer. Eur J Obstet Gynecol Reprod Biol 2008; 137: 77-83.
12. Gynekologisk cellprovskontroll i Sverige 2011. [Cervical Screening in Sweden] (in Swedish) Report. Nationellt Kvalitetsregister för Gynekologisk Cellprovskontroll [National cervical screening register], 2012.
13. Gakidou E, Nordhagen S, Obermeyer Z,. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008; 5: e132.
14. Segnan N, Senore C, Giordano L, et al. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori 1998; 84: 348-53.
15. Morrell S, Taylor R, Zeckendorf S, et al. How much does a reminder letter increase cervical screening among under-screened women in NSW? Aust N Z J Public Health 2005; 29: 78-84.
16. Eaker S, Adami HO, Granath F, et al. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 346-54.
17. Wikstrom I, Stenvall H, Wilander E,. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand 2007; 86: 720-5.
18. Gok M, Heideman DA, van Kemenade FJ, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ 2010; 340: c1040.
19. Virtanen A, Anttila A, Luostarinen T, et al. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer 2010; 128: 2681-7.
20. Virtanen A, Nieminen P, Luostarinen T, et al. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev 2011; 20: 1960-9.
21. Socialstyrelsen. Gynekologisk cellprovskontroll. Förslag till ett screeningprogram 1998 [Guidelines for cervical screening] (in Swedish). SoS Report 1998: 15.
22. Sammanställning av några kvalitetsdata 2010 gällande cervixcancerprevention i Västra Sverige [Compilation of quality data from 2010 concerning prevention of cervical cancer in West Sweden]. (in Swedish). Regionalt Cancercentrum Väst, 2011.
23. Cervixcancerprevention. [Cervical cancer prevention, guidelines for the management of CIN.] (in Swedish). Swedish Society of Obstetricians and Gynaecologists, 2010.
24. Schultz K, Altman D, Moher D,. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332.
25. Ostor AG,. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-92.
26. Barken SS, Rebolj M, Andersen ES, et al. Frequency of cervical intraepithelial neoplasia treatment in a well-screened population. Int J Cancer 2012; 130: 2438-44.
27. Socialstyrelsen. Background to a vaccination programme for the human papilloma virus in Sweden 2007, 2008.
28. Andrae B, Andersson TM, Lambert PC, et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012; 344: e900.
29. Goelen G, De Clercq G, Hanssens S,. A community peer-volunteer telephone reminder call to increase breast cancer- screening attendance. Oncol Nurs Forum 2010; 37: E312-7.
30. Waller J, Bartoszek M, Marlow L, et al. Barriers to cervical cancer screening attendance in England: a population-based survey. J Med Screen 2009; 16: 199-204.
31. Eaker S, Adami HO, Sparen P,. Reasons women do not attend screening for cervical cancer: a population-based study in Sweden. Prev Med 2001; 32: 482-91.
32. Oscarsson MG, Benzein EG, Wijma BE,. Reasons for non-attendance at cervical screening as reported by non-attendees in Sweden. J Psychosom Obstet Gynaecol 2008; 29: 23-31.
33. Waller J, Jackowska M, Marlow L, et al. Exploring age differences in reasons for nonattendance for cervical screening: a qualitative study. BJOG 2012; 119: 26-32.
34. Idestrom M, Milsom I, Andersson-Ellstrom A,. The cervical cancer screening program from a midwife's perspective. Acta Obstet Gynecol Scand 2007; 86: 742-8.
35. Blomberg K, Ternestedt BM, Tornberg S, et al. How do women who choose not to participate in population-based cervical cancer screening reason about their decision? Psychooncology 2008; 17: 561-9.
36. Heranney D, Fender M, Velten M, et al. A prospective randomized study of two reminding strategies: telephone versus mail in the screening of cervical cancer in women who did not initially respond. Acta Cytol 2011; 55: 334-40.
37. Paskett ED, Tatum CM, Mack DW, et al. Validation of self-reported breast and cervical cancer screening tests among low-income minority women. Cancer Epidemiol Biomarkers Prev 1996; 5: 721-6.